Evidence map›Paper›PMID 27224741›Full record

ReviewCurrent opinion in rheumatology2016

Rare variants, autoimmune disease, and arthritis.

Sharon A Chung, Anthony K Shum

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in rheumatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Sharon A ChungaRosalind Russell/Ephraim P. Engleman Rheumatology Research CenterbDepartment of Medicine, Division of Pulmonary and Critical Care, , University of California San Francisco, San Francisco, California, USA.
Anthony K Shum
Rheumatology Research CenterUniversity of California, San Francisco · US

Funding

Translational studies of autoimmune-mediated lung diseaseR01HL122533 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SHUM, ANTHONY · 2015 to 2019
$1.9M
Using genomics to elucidate the pathogenesis of granulomatosis with polyangiitisK23AR063126 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHUNG, SHARON ALANE · 2013 to 2016
$570k
NHLBI NIH HHS R01 HL122533NIAMS NIH HHS K23 AR063126
6 · The paper itself

Abstract

purpose of reviewWe review select studies of newly discovered rare variants in autoimmune diseases with a focus on newly described monogenic disorders, rheumatoid arthritis, and systemic lupus erythematosus. RECENT

findingsTwo new monogenic syndromes of inflammatory arthritis were discovered using whole exome sequencing: the coatomer subunit alpha syndrome because of rare mutations in coatomer subunit alpha and haploinsufficiency of A20 resulting from rare mutations in TNFAIP3. Targeted exon sequencing identified rare variants in IL2RA and IL2RB associated with rheumatoid arthritis. Rare variants in TREX1 and other genes associated with monogenic interferonopathies are also associated with systemic lupus erythematosus. SUMMARY: Rare genetic variants contribute to the heritability of autoimmunity and provide key insight into both novel and previously implicated immunological pathways that are disrupted in autoimmune diseases.

Indexed as

Arthritis, RheumatoidAutoimmune DiseasesAutoimmunityExodeoxyribonucleasesGenetic Predisposition to DiseaseGenetic VariationHumansInterleukin-2 Receptor alpha SubunitInterleukin-2 Receptor beta SubunitLupus Erythematosus, SystemicPhosphoproteinsExodeoxyribonucleasesIL2RA protein, humanIL2RB protein, humanInterleukin-2 Receptor alpha SubunitInterleukin-2 Receptor beta SubunitPhosphoproteinsthree prime repair exonuclease 1

Identifiers

PMID27224741
PMCPMC4910637
OpenAlexW2368984826

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.